Simplex Trading’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $368K | Sell |
36,794
-17,171
| -32% | -$155K | ﹤0.01% | 3991 |
|
|
2026
Q1 | $514K | Buy |
+53,965
| New | +$419K | ﹤0.01% | 3224 |
|
|
2025
Q4 | – | Sell |
-40,602
| Closed | -$308K | – | 8555 |
|
|
2025
Q3 | $308K | Buy |
40,602
+29,118
| +254% | +$242K | ﹤0.01% | 4419 |
|
|
2025
Q2 | $102K | Sell |
11,484
-21,665
| -65% | -$202K | ﹤0.01% | 5214 |
|
|
2025
Q1 | $248K | Buy |
+33,149
| New | +$267K | ﹤0.01% | 4097 |
|
|
2024
Q3 | – | Sell |
-26,565
| Closed | -$202K | – | 8471 |
|
|
2024
Q2 | $164K | Buy |
26,565
+9,470
| +55% | +$52.3K | ﹤0.01% | 4839 |
|
|
2024
Q1 | $86K | Buy |
+17,095
| New | +$96.1K | ﹤0.01% | 5738 |
|
|
2023
Q4 | – | Sell |
-8,064
| Closed | -$46.7K | – | 8761 |
|
|
2023
Q3 | $57K | Buy |
+8,064
| New | +$57.9K | ﹤0.01% | 5674 |
|
|
2023
Q2 | – | Sell |
-63,313
| Closed | -$508K | – | 8956 |
|
|
2023
Q1 | $528K | Buy |
63,313
+23,231
| +58% | +$224K | ﹤0.01% | 3208 |
|
|
2022
Q4 | $460K | Buy |
+40,082
| New | +$500K | ﹤0.01% | 3235 |
|
|
2022
Q3 | – | Sell |
-87,260
| Closed | -$1.12M | – | 9888 |
|
|
2022
Q2 | $923K | Buy |
87,260
+21,075
| +32% | +$217K | ﹤0.01% | 2711 |
|
|
2022
Q1 | $1.08M | Buy |
66,185
+61,765
| +1,397% | +$991K | ﹤0.01% | 2828 |
|
|
2021
Q4 | $61K | Sell |
4,420
-47,315
| -91% | -$626K | ﹤0.01% | 6960 |
|
|
2021
Q3 | $841K | Sell |
51,735
-1,274
| -2% | -$20.1K | ﹤0.01% | 3327 |
|
|
2021
Q2 | $838K | Buy |
53,009
+13,138
| +33% | +$179K | ﹤0.01% | 3386 |
|
|
2021
Q1 | $0 | Sell |
39,871
-210,641
| -84% | -$2.17M | ﹤0.01% | 8804 |
|
|
2020
Q4 | $1.87M | Buy |
250,512
+224,394
| +859% | +$1.16M | ﹤0.01% | 1837 |
|
|
2020
Q3 | $89K | Buy |
26,118
+15,679
| +150% | +$67.2K | ﹤0.01% | 5030 |
|
|
2020
Q2 | $49K | Buy |
+10,439
| New | +$41.7K | ﹤0.01% | 5506 |
|
|
2020
Q1 | – | Sell |
-2,903
| Closed | -$7.99K | – | 7581 |
|
|
2019
Q4 | $10K | Buy |
+2,903
| New | +$7.3K | ﹤0.01% | 6365 |
|
|
2019
Q1 | – | Sell |
-3,682
| Closed | -$31.5K | – | 7123 |
|
|
2018
Q4 | $29K | Sell |
3,682
-3,616
| -50% | -$28.1K | ﹤0.01% | 5015 |
|
|
2018
Q3 | $55K | Buy |
+7,298
| New | +$49K | ﹤0.01% | 5065 |
|
|
2017
Q3 | – | Sell |
-59,614
| Closed | -$305K | – | 5891 |
|
|
2017
Q2 | $331K | Buy |
59,614
+55,402
| +1,315% | +$337K | 0.01% | 886 |
|
|
2017
Q1 | $35K | Sell |
4,212
-28,003
| -87% | -$195K | ﹤0.01% | 2684 |
|
|
2016
Q4 | $203K | Buy |
32,215
+4,486
| +16% | +$23.3K | 0.01% | 1045 |
|
|
2016
Q3 | $122K | Buy |
+27,729
| New | +$111K | 0.01% | 1379 |
|
|
2015
Q2 | – | Sell |
-399
| Closed | -$4.54K | – | 5170 |
|
|
2015
Q1 | $3K | Buy |
399
+253
| +173% | +$2.62K | ﹤0.01% | 3808 |
|
|
2014
Q4 | $2K | Buy |
+146
| New | +$1.61K | ﹤0.01% | 3676 |
|
Other funds holding BCRX
RCM
DM
TCM
PA
JT
VPC
Simplex Trading's BCRX Position: Q2 2026 in Review
Simplex Trading reduced its BioCryst Pharmaceuticals (BCRX) stake by 32% in Q2 2026, selling an estimated $155K and leaving 36,794 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #3991.
Simplex Trading first reported a position in BCRX in Q4 2014 and has held it in 28 quarters since. The position peaked at $1.87M in Q4 2020. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.
- Simplex Trading held 36,794 shares of BioCryst Pharmaceuticals worth $368K as of Q2 2026.
- Simplex Trading sold 17,171 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $155K.
- BioCryst Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #3991 holding.
- Simplex Trading first reported a position in BioCryst Pharmaceuticals in Q4 2014 and has held it in 28 quarters since.
- Simplex Trading's BioCryst Pharmaceuticals position peaked at $1.87M in Q4 2020.
- 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.